Skip to main content
. 2020 Oct 1;47(4):991–1001. doi: 10.1007/s00068-020-01505-y

Table 2.

MINORS quality assessment

Study Clearly stated aim Inclusion consecutive patients Prospective data collection Appropriate endpoints to the aim Unbiased
Study endpoint
Appropriate follow-up period Loss to follow-up < 5% Prospective calculation of study size Adequate control group Contemporary groups Baseline equivalence of groups Adequate statistical analysis Total quality score
Jiang et al. [11] 1 N/a 0 2 0 2 N/a N/a N/a N/a N/a N/a 5 / 16
Klei et al. [24] 2 2 0 2 0 2 2 0 2 2 1 2 17 / 24
Krinner et al. [3] 1 0 0 1 0 2 2 0 N/a N/a N/a N/a 6 / 16
Labbe et al. [10] 1 0 0 2 0 0 0 0 N/a N/a N/a N/a 3 / 16
Regauer et al. [26] 1 N/a 0 2 0 2 N/a N/a N/a N/a N/a N/a 5 / 16
Sarkeshik et al. [33] 1 N/a 0 1 0 2 N/a N/a N/a N/a N/a N/a 4 / 16

MINORS criteria: 0 = not reported, 1 = reported but inadequate, 2 = reported and adequate. N/a, not applicable

For case reports and case series, the eight criteria for non-comparative studies were used (maximum total score of 16 points). For the retrospective cohort study, four criteria for comperative studies were added (maximum total score of 24 points)